Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Liublinska

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Epidemiology|August 2, 2012
Re: "dealing with missing outcome data in randomized trials and observational studies"Victoria Liublinska, Donald B Rubin
Statistics in Medicine|May 22, 2014
Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trialVictoria Liublinska, Donald B Rubin
The Journal of Arthroplasty|June 17, 2011
Postoperative complication rates in the "super-obese" hip and knee arthroplasty populationRan Schwarzkopf, Sean L Thompson, Sean J Adwar, et al.
Scientific Reports|August 4, 2016
Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved SafetyEdwin Vazquez-Cintron, Luis Tenezaca, Christopher Angeles, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Epidemiology|August 2, 2012
Re: "dealing with missing outcome data in randomized trials and observational studies"Victoria Liublinska, Donald B Rubin
Statistics in Medicine|May 22, 2014
Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trialVictoria Liublinska, Donald B Rubin
The Journal of Arthroplasty|June 17, 2011
Postoperative complication rates in the "super-obese" hip and knee arthroplasty populationRan Schwarzkopf, Sean L Thompson, Sean J Adwar, et al.
Scientific Reports|August 4, 2016
Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved SafetyEdwin Vazquez-Cintron, Luis Tenezaca, Christopher Angeles, et al.
Pageof 1